Notoginsenoside R1 relieves the myocardial infarction via activating the JAK2/STAT3 signaling pathway in vivo and in vitro
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Notoginsenoside R1 relieves the myocardial infarction via activating the JAK2/STAT3 signaling pathway in vivo and in vitro
Authors
Keywords
-
Journal
Bioengineered
Volume 13, Issue 3, Pages 5653-5662
Publisher
Informa UK Limited
Online
2022-03-10
DOI
10.1080/21655979.2022.2037366
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients
- (2022) Songtao Du et al. Bioengineered
- Circular RNA Rbms1 inhibited the development of myocardial ischemia reperfusion injury by regulating miR-92a/BCL2L11 signaling pathway
- (2022) Ling Jin et al. Bioengineered
- The role of JAK/STAT signaling pathway and its inhibitors in diseases
- (2020) Ping Xin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Notoginsenoside R1 Suppresses Inflammatory Signaling and Rescue Renal Ischemia-reperfusion Injury in Experimental Rats
- (2020) Chuming Fan et al. MEDICAL SCIENCE MONITOR
- Extended Multiple Aperture Mapdrift-Based Doppler Parameter Estimation and Compensation for Very-High-Squint Airborne SAR Imaging
- (2019) Zhichao Zhou et al. SENSORS
- Notoginsenoside R1 (NGR1) Attenuates Chronic Atrophic Gastritis in Rats
- (2019) Chao Luo et al. MEDICAL SCIENCE MONITOR
- Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction
- (2019) Paul-Mihai Boarescu et al. Oxidative Medicine and Cellular Longevity
- Molecular imaging of cardiac remodelling after myocardial infarction
- (2018) Daniel Curley et al. BASIC RESEARCH IN CARDIOLOGY
- Notoginsenoside R1 ameliorates diabetic encephalopathy by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation
- (2018) Yadong Zhai et al. Oncotarget
- Resveratrol activates endogenous cardiac stem cells and improves myocardial regeneration following acute myocardial infarction
- (2017) Lin Ling et al. Molecular Medicine Reports
- Treatment effect of a flavonoid prescription on duck virus hepatitis by its hepatoprotective and antioxidative ability
- (2016) Yun Chen et al. PHARMACEUTICAL BIOLOGY
- Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress- related signaling pathways
- (2016) Yingli Yu et al. Scientific Reports
- Protective Effect of Notoginsenoside R1 on an APP/PS1 Mouse Model of Alzheimer's Disease by Up-Regulating Insulin Degrading Enzyme and Inhibiting Aβ Accumulation
- (2015) Zhi Li et al. CNS & Neurological Disorders-Drug Targets
- Cardiovascular remodelling in coronary artery disease and heart failure
- (2014) Gerd Heusch et al. LANCET
- Notoginsenoside R1 attenuates cardiac dysfunction in endotoxemic mice: an insight into oestrogen receptor activation and PI3K/Akt signalling
- (2012) Bing Sun et al. BRITISH JOURNAL OF PHARMACOLOGY
- The myocardial JAK/STAT pathway: From protection to failure
- (2008) K BOENGLER et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started